Last reviewed · How we verify
Shan 5
At a glance
| Generic name | Shan 5 |
|---|---|
| Sponsor | Shantha Biotechnics Limited |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease (NA)
- A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease
- Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine (PHASE4)
- Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine (PHASE4)
- Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Shan 5 CI brief — competitive landscape report
- Shan 5 updates RSS · CI watch RSS
- Shantha Biotechnics Limited portfolio CI